Sign in

CIK 0001642380

  • Non-accelerated filer
  • Smaller reporting company

Insight Molecular Diagnostics Inc.

Sign in to watch
Ticker
IMDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
271041563
Phone
+1 949-409-7600
Business address
2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
Former names
OncoCyte Corp, Oncocyte Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 23 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-09-11 BROADWOOD PARTNERS, L.P. 10% owner Purchase +0 11,098,267
2019-07-17 Redmond Cavan M. Director Grant or award · Option to Purchase Common Stock +50,000 50,000
2019-07-17 MOHANTY ADITYA P. Director Grant or award · Option to Purchase Common Stock +45,000 45,000
2019-07-17 KINGSLEY ALFRED D Director Grant or award · Option to Purchase Common Stock +45,000 45,000
2019-07-17 Last Andrew J. Director Grant or award · Option to Purchase Common Stock +45,000 45,000
2019-07-17 Arno Andrew Director Grant or award · Option to Purchase Common Stock +45,000 45,000
2019-07-05 BIOTIME INC 10% owner Sale −2,250,000 $2.00 $4.5M 12,424,244
2019-07-02 BROADWOOD PARTNERS, L.P. 10% owner Purchase +1,000,000 $2.00 $2.0M 9,098,267
2019-07-02 BROADWOOD PARTNERS, L.P. 10% owner Purchase +0 $2.00 $0 9,098,267
2019-07-01 ANDREWS RONALD ASBURY Chief Executive Officer Grant or award · Option to Purchase Common Stock +950,000 950,000
2019-03-14 ANNETT WILLIAM President and CEO Grant or award · Option to Purchase Common Stock +390,000 390,000
2019-03-14 Levine Mitchell S Chief Financial Officer Grant or award · Option to Purchase Common Stock +245,000 245,000
2019-03-14 Levine Mitchell S Chief Financial Officer Grant or award · Restricted Stock Units +20,000 20,000
2019-03-14 HESTERBERG LYNDAL K. Chief Scientific Officer Grant or award · Option to Purchase Common Stock +350,000 350,000
2019-03-14 Parker Albert P Chief Operating Officer Grant or award · Option to Purchase Common Stock +200,000 200,000
2019-02-15 MOHANTY ADITYA P. Director Grant or award · Option to Purchase Common Stock +33,750 33,750
2019-02-08 BROADWOOD PARTNERS, L.P. 10% owner Purchase +533,333 $3.75 $2.0M 8,098,267
2019-02-08 BROADWOOD PARTNERS, L.P. 10% owner Purchase +0 $3.75 $0 8,098,267
2018-08-30 KINGSLEY ALFRED D Director Grant or award · Option to Purchase Common Stock +45,000 45,000
2018-08-30 Last Andrew J. Director Grant or award · Option to Purchase Common Stock +45,000 45,000

Page 18 of 20 · 383 trades